CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017		Sep. 30, 2016
Cash flows from operating activities:
Net loss	$ (9,070)		$ (6,554)
Reconciliation of net loss to net cash (used in) provided by operating activities
Depreciation and amortization of fixed assets	1,264		679
Provision for write down of inventory	1,489		1,000
Provision for bad debt	1,738		0
Stock based compensation	2,427		2,255
Amortization of debt issuance costs	695		611
Amortization of intangibles	2,143		2,146
Foreign currency exchange gain	(6,645)		(1,295)
Amortization of debt discount on convertible 3.75% senior notes	6,376		5,606
Loss on impairment	113		0
Loss on disposal of property	0		16
Changes in operating assets and liabilities
Accounts receivable	(4,960)		(3,168)
Inventories	(2,767)		(4,358)
Prepaid expenses and other current receivables	510		3,718
Other assets	21		283
Accounts payable and accrued expenses	4,006		2,356
Deferred income	0		(475)
Net cash (used in) provided by operating activities	(2,660)		2,820
Cash flows from investing activities:
Capital expenditures	(26,002)		(11,956)
Product acquisition costs	0		(3,422)
Net cash used in investing activities	(26,002)		(15,378)
Cash flows from financing activities:
Proceeds from exercise of common stock options	269		35
Principal payments on capital lease obligations	0		(70)
Recovery from stockholder, net	0		(36)
Net cash provided by (used in) financing activities	269		(71)
Effect of exchange rate on cash and cash equivalents	618		70
Net decrease in cash and cash equivalents	(28,393)		(12,629)
Cash and cash equivalents at beginning of period	66,006	[1]	87,191
Cash and cash equivalents at end of period	38,231		74,632
Supplemental Cash flow information:
Cash payments for interest	2,695		2,698
Cash payments for income taxes	102		70
Non cash investing and financing transactions:
Issuance of stock to a consultant	0		189
Acquisition of capital expenditures in accounts payable and accrued expenses	5,029		42
Capitalized interest in capital expenditures	1,058		139
Capitalized stock compensation in capital expenditures	$ 101		$ 39

[1] Derived from the audited December 31, 2016 financial statements